SGP compared with PBLS: revenue, margins and what each company keeps, and the suppliers and customers both name

SGPSpyGlass Pharma, Inc.

Mkt capRevenueRevenue

PBLSParabilis Medicines, Inc.

Mkt capRevenueRevenue

Compare

SGPSpyGlass Pharma, Inc.

PBLSParabilis Medicines, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SGP 1

—Regents of the University of Colorado (CU)unlistedsupplier

Shared 0

No shared counterparties.

Only PBLS 2

REGNRegeneron Pharmaceuticalscustomer

—Alcamiunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

SGPSpyGlass Pharma, Inc.

34.04▼−1.19%· post 34.04· delayed

Mkt cap$1.2BRevenue—

PBLSParabilis Medicines, Inc.

27.29▼−6.70%· post 30.39· delayed

After hoursNov 4 '26delayed

Mkt cap$845.6MRevenue$148,000Q2 FY26

Compare

After hoursNov 4 '26delayed

SGPSpyGlass Pharma, Inc.

PBLSParabilis Medicines, Inc.

34.04▼−1.19%post 34.04delayed

Price

27.29▼−6.70%post 30.39delayed

$1.2B

Mkt cap

$845.6M

—

Revenue

$148,000Q2 FY26

SGP34.04▼−1.19%vsPBLS27.29▼−6.70%After hoursNov 4 '26delayed